Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RBM10-TFE3 fusions: A FISH-concealed anomaly in adult renal cell carcinomas displaying a variety of morphological and genomic features: Comprehensive study of six novel cases.
Di Mauro I, Dadone-Montaudie B, Sibony M, Ambrosetti D, Molinie V, Decaussin-Petrucci M, Bland V, Arbaud C, Cenciu B, Arbib F, Just PA, Derman J, Rioux-Leclercq N, Pedeutour F; CARARE French Network. Di Mauro I, et al. Genes Chromosomes Cancer. 2021 Nov;60(11):772-784. doi: 10.1002/gcc.22985. Epub 2021 Aug 6. Genes Chromosomes Cancer. 2021. PMID: 34358382
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
Italiano A, Di Mauro I, Rapp J, Pierron G, Auger N, Alberti L, Chibon F, Escande F, Voegeli AC, Ghnassia JP, Keslair F, Laé M, Ranchère-Vince D, Terrier P, Baffert S, Coindre JM, Pedeutour F. Italiano A, et al. Among authors: di mauro i. Lancet Oncol. 2016 Apr;17(4):532-538. doi: 10.1016/S1470-2045(15)00583-5. Epub 2016 Mar 10. Lancet Oncol. 2016. PMID: 26970672 Clinical Trial.
Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.
Tardy MP, Di Mauro I, Ebran N, Refae S, Bozec A, Benezery K, Peyrade F, Guigay J, Sudaka-Bahadoran A, Badoual C, Pedeutour F, Saada-Bouzid E. Tardy MP, et al. Among authors: di mauro i. Oral Oncol. 2018 May;80:104-107. doi: 10.1016/j.oraloncology.2018.04.001. Epub 2018 Apr 7. Oral Oncol. 2018. PMID: 29631799 No abstract available.
Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.
Dadone-Montaudié B, Alberti L, Duc A, Delespaul L, Lesluyes T, Pérot G, Lançon A, Paindavoine S, Di Mauro I, Blay JY, de la Fouchardière A, Chibon F, Karanian M, MacGrogan G, Kubiniek V, Keslair F, Cardot-Leccia N, Michot A, Perrin V, Zekri Y, Coindre JM, Tirode F, Pedeutour F, Ranchère-Vince D, Le Loarer F, Pissaloux D. Dadone-Montaudié B, et al. Among authors: di mauro i. Mod Pathol. 2018 Nov;31(11):1683-1693. doi: 10.1038/s41379-018-0089-4. Epub 2018 Jun 28. Mod Pathol. 2018. PMID: 29955147 Free article.
Clinicopathologic and molecular analyses of cutaneous leiomyosarcoma: A retrospective, multicenter study of 79 cases.
Planet C, Dalle S, Dereure O, Stoebner PE, Picot MC, Soler M, Meunier L, Cardot-Leccia N, Kubiniek V, Di Mauro I, Delhorbe M, Lacour JP, Passeron T, Pedeutour F, Montaudié H, Dadone-Montaudié B. Planet C, et al. Among authors: di mauro i. J Am Acad Dermatol. 2023 Jan;88(1):215-216. doi: 10.1016/j.jaad.2022.03.066. Epub 2022 Apr 27. J Am Acad Dermatol. 2023. PMID: 35489551 No abstract available.
BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature.
Gaubert A, Kervarrec T, Montaudié H, Burel-Vandenbos F, Cardot-Leccia N, Di Mauro I, Fabas T, Tallet A, Kubiniek V, Pedeutour F, Dadone-Montaudié B. Gaubert A, et al. Among authors: di mauro i. J Invest Dermatol. 2023 Jul;143(7):1178-1186. doi: 10.1016/j.jid.2023.01.014. Epub 2023 Feb 7. J Invest Dermatol. 2023. PMID: 36754117 Free article.
12 results